If you would like more structured support to get on top of your diabetes while using insulin, you may also be interested in the Type 2 Diabetes personalised online program or my free diabetes masterclass webinar
Our expertly-crafted blend ensures that each treatment is not only safe but also delivers impressive results.The process is quick and minimally invasive, with most clients experiencing little to no discomfort
Clinical Evidence Several clinical trials and studies underscore the cardiovascular benefits of GLP-1 receptor agonists: SUSTAIN-6 Trial : This pivotal trial demonstrated a significant reduction in major adverse cardiovascular events (MACE) among patients treated with GLP-1 compared to placebo
Assessment of Cellular GSH and GSSG Content To investigate the GSH and GSSG content in GSTP1 - and mock-transfected HepG2 cells, concentrations of total GSH and GSSG were measured using the GSH/GSSG-Glo TM Glutathione Assay kit (Promega, Madison, WI, United States)
Short-acting GLP-1RAs, such as beinaglutide, lixisenatide, and exenatide, primarily reduce postprandial blood glucose and delay stomach emptying (Kaneto et al., 2021)
